BioNTech (BNTX)
(Delayed Data from NSDQ)
$102.50 USD
+3.02 (3.04%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $102.52 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
BioNTech SE Sponsored ADR [BNTX]
Reports for Purchase
Showing records 1 - 20 ( 154 total )
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Key Takeaway From Biotech Breakthroughs Oncology Event: The Rise of PRAME-Targeted Therapies
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BNT122 Elicits Long-Term Responses; Patent Lawsuit Paused; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Collaboration Inked With Autolus, Expanding Manufacturing; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 21124
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 2124
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
First Patient Dosed in BNT323 Phase 3 Trial; Lowering PT to $107
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 12124
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 11124
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 1124
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
BNT323/DB-1303 Receives Breakthrough Therapy Designation; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 122123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Legal Winds Continue to Blow in Favor of BioNTech; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 12123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
European Patent Office Revokes Moderna Patent; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
COVID-19 Vaccine Sales Flagging; 3Q23 Financials; Lowering PT to $133
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 111123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 11123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Combo Influenza COVID-19 Vaccine Delivers; ESMO Takeaways; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Company: BioNTech SE Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BNTX 102123
Provider: Stock Traders Daily
Analyst: Research Department